We Provide One-Stop Cross-Border BD Solution

Our services

  • Advise cross-border or domestic BD via our broad network of “decision makers”, effective public relations, and the creation of scientific advisory board.

  • Scientific advisor to Mianus Capital, a boutique private equity firm (www.mianuscapital.com).

  • ISWTB created InScienceWeTrust Community (ISWTC) in 2020, with ~1K healthcare professionals around the world. A few members’ businesses have joined force with ISWTB to help our clients to enter the US market.

Our founder

Dr. Leon Tang founded InScienceWeTrust BioAdvisors in 2022. Dr. Tang is a business development expert who has closed BD transactions valued total ~$1.2 billion, a connector with 3,000+ professional contacts, and an accomplished scientist of 50+ publications with 4,000+ citations and H-index of 32, as of 2022

  • InScienceWeTrust BioAdvisory - Founding Partner & Principal Consultant

    Shanghai Henlius Biotechnology - Head of Business Development Search & Evaluation

    Barclays Investment Bank - SMID-Cap Biotech Equity Research Analyst

    Cancer Research Institute - Philanthropic Venture Fund Senior Manager

  • BioSpark Group - advisor since 2020

    BioKatalyst - membership since 2020

    Sino-American Pharmaceutical Professionals Association (SAPA) - membership since 2010

  • Memorial Sloan Kettering Cancer Center - Research Fellow in radiopharmaceuticals and immuno-oncology

    Icahn School of Medicine at Mount Sinai - Ph.D. in nanomedicine and immunotherapy

    Nankai University - M.S. in Immunology and Biochemistry

    Tianjin University - B.E. in Biomedical Engineering

“I am hard-working, loyal, dedicated, smart, and good-looking. And I endorse Leon as a very decent human being”
— The German shepherd